- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Relapsing Remitting Multiple Sclerosis; Higher Dose of CD20 Antibody Ocrelizumab; Efficacy, Safety a
Total 496551 results
-
Hoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma, Non-Hodgkin's LymphomaHong Kong, Germany, Philippines, Taiwan, Turkey, Canada, Australia, Austria, New Zealand, Thailand, Hungary, Italy, Korea, Republic of, Romania, Netherlands, Brazil, Indonesia, Croatia, Egypt, Portugal, Sweden, Colombia, Argentina, De... and more
-
Yang TaoCompleted
-
Hebei Yanda Ludaopei HospitalChina Immunotech (Beijing) Biotechnology Co., Ltd.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFatigue | Thrombocytopenia | Fever | Chronic Lymphocytic Leukemia | Lymphadenopathy | Small Lymphocytic Lymphoma | Hypogammaglobulinemia | Lymphocytosis | Night Sweats | ParaproteinemiaUnited States
-
Beijing Tsinghua Chang Gung HospitalChina Immunotech Pharmaceuticals Co.Ltd.Suspended
-
M.D. Anderson Cancer CenterCureTech LtdCompleted
-
Novartis PharmaceuticalsTerminatedPemphigus VulgarisUnited States, Australia, Greece, Israel, Italy, Japan, Poland, Romania
-
Lymphoma Study AssociationAmgenCompletedUntreated CD20-positive Large B-cell LymphomaFrance
-
The Lymphoma Academic Research OrganisationHoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma CD20 PositiveFrance, Belgium
-
Fondazione Italiana Linfomi ONLUSTerminatedCD20 Positive Diffuse Large B-cell Lymphoma | Elderly Unfit PatientsItaly
-
University Hospital, GhentCompletedEarly and Severe Systemic SclerosisBelgium
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter Syndrome | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
JHL Biotech, Inc.Terminated
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownDiffuse Large B-cell LymphomaChina
-
Shanghai Henlius BiotechCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedRefractory Chronic Lymphocytic LeukemiaUnited States
-
Nilratan Sircar Medical CollegeRecruiting
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKline; Millennium Pharmaceuticals,...TerminatedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterBayerCompletedChronic Lymphocytic LeukemiaUnited States
-
Universität des SaarlandesSpectrum Pharmaceuticals, Inc; German High-Grade Non-Hodgkin's Lymphoma Study...CompletedCD20+ Aggressive B-Cell LymphomaGermany
-
Nilratan Sircar Medical CollegeCompleted
-
Qiu LuguiNanjing Legend Biotech Co.RecruitingB-cell Lymphoma Refractory | B-cell Lymphoma RecurrentChina
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminatedNon-Hodgkin's Lymphoma (NHL)United States
-
Henan Cancer HospitalHenan Hualong Biotechnology CompanyUnknownRefractory | B-Cell Lymphoma Stage I | RelapsedChina
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Genentech, Inc.; Pharmacyclics LLC.RecruitingNon-Hodgkin's Lymphoma | Indolent Non-hodgkin Lymphoma | Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage II Nodal Marginal Zone Lymphoma | Ann Abor Stage III B-Cell Non-Hodgkin Lymphoma | Ann Arbor... and other conditionsUnited States
-
Centre de Recherches et d'Etude sur la Pathologie...Completed
-
GlaxoSmithKlineCompletedLymphoma, FollicularUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Worldwide Clinical TrialsSuspendedB-cell Non-Hodgkin's LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingEBV-Related Post-Transplant Lymphoproliferative Disorder | Monomorphic Post-Transplant Lymphoproliferative Disorder | Polymorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Polymorphic Post-Transplant Lymphoproliferative... and other conditionsUnited States
-
Precision BioSciences, Inc.CompletedLymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B-cell Non Hodgkin Lymphoma | Leukemia, Lymphocytic, Chronic | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)RecruitingFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | MALT Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Indolent Lymphoma | Refractory B-Cell LymphomaUnited States, Australia, China
-
Lymphoma Study AssociationTerminatedCD20-Positive Large B-Cell LymphomaFrance
-
Chinese PLA General HospitalRecruitingInert Non Hodgkin's LymphomaChina
-
University of MiamiCompletedMarginal Zone LymphomaUnited States
-
Dr. Reddy's Laboratories LimitedCompleted
-
The First Affiliated Hospital with Nanjing Medical...Nanjing Legend Biotech Co.RecruitingRelapsed and Refractory B-cell Non-Hodgkin LymphomaChina
-
Istituto Giannina GasliniBambino Gesù Hospital and Research InstituteTerminatedNephrotic Syndrome Steroid-DependentItaly
-
National University Hospital, SingaporeNational University of SingaporeUnknownPilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell MalignanciesNon-Hodgkin's Lymphoma | B-Cell Chronic Lymphocytic LeukemiaSingapore
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedDLBCLBulgaria, Estonia, France, Hungary, Italy, Latvia, Poland, Russian Federation, Spain, Ukraine
-
Centre Hospitalier Universitaire de BesanconTerminatedHematological Malignancies BFrance
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicUnited States, United Kingdom
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Jonsson Comprehensive Cancer CenterParker Institute for Cancer ImmunotherapyRecruitingRecurrent Mantle Cell Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | CD20 Positive | Refractory Mantle Cell Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Refractory... and other conditionsUnited States
-
The Lymphoma Academic Research OrganisationRoche Pharma AGRecruitingFollicular LymphomaFrance
-
University of WashingtonMerck Sharp & Dohme LLCActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States